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Background: Increasing evidence demonstrates that repetitive transcranial magnetic
stimulation (rTMS) treatment of the dorsolateral prefrontal cortex is beneficial for
improving cognitive function in patients with Alzheimer’s disease (AD); however, the
underlying mechanism of its therapeutic effect remains unclear.
Objectives/Hypothesis: The aim of this study was to investigate the impact of rTMS
to the dorsolateral prefrontal cortex on functional connectivity along with treatment
response in AD patients with different severity of cognitive impairment.
Methods: We conducted a 2-week treatment course of 10-Hz rTMS over the left
dorsolateral prefrontal cortex in 23 patients with AD who were split into the mild or
moderate cognitive impairment subgroup. Resting state electroencephalography and
general cognition was assessed before and after rTMS. Power envelope connectivity
was used to calculate functional connectivity at the source level. The functional
connectivity of AD patients and 11 cognitively normal individuals was compared.
Results: Power envelope connectivity was higher in the delta and theta bands but
lower in the beta band in the moderate cognitive impairment group, compared to
the cognitively normal controls, at baseline (p < 0.05). The mild cognitive impairment
group had no significant abnormities. Montreal Cognitive Assessment scores improved
after rTMS in the moderate and mild cognitive impairment groups. Power envelope
connectivity in the beta band post-rTMS was increased in the moderate group (p < 0.05)
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but not in the mild group. No significant changes in the delta and theta band were found
after rTMS in both the moderate and mild group.
Conclusion: High-frequency rTMS to the dorsolateral prefrontal cortex modulates
electroencephalographic functional connectivity while improving cognitive function in
patients with AD. Increased beta connectivity may have an important mechanistic role
in rTMS therapeutic effects.
Keywords: repetitive transcranial magnetic stimulation, electroencephalographic functional connectivity, power
envelope connectivity, Alzheimer’s disease, cognitive function
INTRODUCTION
Alzheimer’s disease (AD) is an irreversible neurodegenerative
disorder that progressively destroys memory, language, other
thinking abilities, as well as motor skills such as balance and
mobility (Voglein et al., 2019; Alzheimer’s Association, 2021).
Several randomized controlled studies have advocated using
repetitive transcranial magnetic stimulation (rTMS) applied to
the left dorsolateral prefrontal cortex (DLPFC) as a potential
intervention to improve cognitive function in patients with
Alzheimer’s disease (AD) or its possible precursor, mild cognitive
impairment (MCI) (Cotelli et al., 2006; Ahmed et al., 2012;
Rabey et al., 2013). Furthermore, considering the link between
cognition and motor behavior, with evidence that stable gait relies
on intact cognition, rTMS therapy might be an innovative tool
for falls prevention in AD (Amboni et al., 2013). Nevertheless,
the understanding of the mechanism(s) by which rTMS exerts
its effects of improving cognition is incomplete. Animal models
have shown that magnetic stimulation improves cognitive
performance by attenuating the Aβ load, strengthening synaptic
function, or increasing neurogenesis (Ueyama et al., 2011; Ma
et al., 2017; Zhen et al., 2017). These rTMS-induced molecular
and cellular alterations may act as the substrate of the brain
network level changes, which have been more thoroughly
studied in humans (Tik et al., 2017). rTMS evidently results in
clinical improvement partially by modifying brain connectivity
in patients with neuropsychological diseases such as stroke,
Parkinson’s disease, and major depressive disorder (Beynel et al.,
2020). Given that disrupted functional connectivity is a feature of
AD (Briels et al., 2020a; Franzmeier et al., 2020; Smailovic et al.,
2020), this neural mechanism may underpin rTMS treatment and
is therefore worthy of further investigation.
Electroencephalography (EEG) is a neurophysiologic
technique for evaluating brain activity. It can capture neural
activity with high temporal resolution and no notable adverse
effects. This low-cost technology is readily available in clinical
settings. A recent white paper has advocated using EEG
as a multiscale methodology for detecting the effects of
neuropathological processes and the effects of therapy on brain
activity and connectivity in preclinical and clinical research
(Babiloni et al., 2020). Investigators have most frequently
reported that delta and theta power density is increased across
the whole brain, while alpha and/or beta powers are decreased
in the posterior head in patients with AD, compared to normal
individuals (Babiloni et al., 2016; Gouw et al., 2017). Distinct
from power density, functional connectivity analysis has revealed
impaired communication within long-range brain networks, and
EEG connectivity data have strongly supported the hypothesis of
AD as a disconnection syndrome (Delbeuck et al., 2003). Most
previous studies have found decreased coherence of alpha and
beta rhythms globally or locally in people with AD, compared to
normal controls. However, data supporting alterations in delta
and theta coherence are contradictory, with a widespread or
regional increase or decrease being reported in different studies
(Jeong, 2004; Babiloni et al., 2016).
Of note, traditional EEG connectivity metrics such as
coherence have limitations because they do not account for
the limited spatial resolution of EEG and volume conduction,
which can result in an inaccurate interpretation of connectivity
(He et al., 2019). Power envelope connectivity (PEC) is a novel
method that biases against signals with zero phase-lag through
orthogonalization to reduce the effects of volume conduction.
As a result, PEC provides a more conservative estimate of
functional connectivity. PEC has been introduced for addressing
this artifactual correlation in magnetoencephalography (MEG)
and EEG functional connectivity analysis (Hipp et al., 2012). In
an MEG study (Koelewijn et al., 2017), orthogonalized amplitude
envelope correlation (which is similar to PEC) in the source-space
was compared between AD patients and controls. The patients
had decreased alpha connectivity in the left superior temporal
pole and disruption of the beta band in the right lingual gyrus,
precuneus, and left supramarginal gyrus. A recent AD clinical
trial found that, compared to a placebo, a novel glutaminyl-
cyclase inhibitor increased the channel-level orthogonalized
amplitude envelope correlation in the alpha band globally,
which suggested the drug treatment had a network level effect
(Briels et al., 2020b) and may serve as a mechanism of rTMS
efficacy.
Some reports indicate a correlation between functional
connectivity and severity of cognitive decline in AD (Hata et al.,
2016; Badhwar et al., 2017) and the probable different effects
of rTMS in patients at different stages of cognitive dysfunction
(Cotelli et al., 2008). Therefore, the purpose of this study was
to investigate how rTMS to the left DLPFC exerts its effects on
cognitive enhancement in AD patients with different severity
of cognitive decline. We hypothesized that left DLPFC rTMS
would improve cognitive function in AD patients with mild or
moderate cognitive impairment, at least in part, by changing
the electroencephalographic functional connectivity in different
bands, globally or locally.
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MATERIALS AND METHODS
Study Participants
This study was approved by the Institutional Review Board
of Shenzhen People’s Hospital (Shenzhen, China) and was
conducted in accordance with the Declaration of Helsinki
guidelines (chictr.org.cn identifier ChiCTR1800019199). All
participants provided written informed consent. From March
2019 to May 2020, 23 patients were recruited from the
Department of Neurology in Shenzhen People’s Hospital. For
selecting patients, the inclusion criteria were as follows: (a)
meeting the diagnostic criteria for probable AD based on
the National Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA), and the Diagnostic
and Statistical Manual of Mental Disorders-V (DSM-V) criteria;
(b) no plan to change medication during the study and for at least
2 months prior to starting the study; (c) 50–75 years old; and
(d) self-reported right-handedness. The exclusion criteria were:
(a) severe cognitive impairment as defined by a score of < 10
on the Montreal Cognitive Assessment (MoCA)1; (b) severe
depression as determined by a score >20 on the 24-item Hamilton
Depression Rating Scale (HAMD) (Carrozzino et al., 2020); (c) a
history of other psychiatric or other neurological disorders, such
as schizophrenia, Parkinson’s disease, and multiple sclerosis; (d)
a history of brain injury or cranial neurosurgery; (e) a history of
alcohol or drug abuse; (f) any severe chronic systemic illness, such
as heart failure and renal failure; and (g) any contraindication for
rTMS (Rossi et al., 2009), such as a metallic implanted device in
or near the head and aneurysms. Patients were divided into two
groups based on the median split of their Montreal Cognitive
Assessment (MoCA) score (i.e., 18/30) (Nasreddine et al., 2005).
Twelve patients with a MoCA score ≥ 18 were grouped as having
mild cognitive impairment (i.e., mild group), and 11 patients with
a MoCA score < 18 were grouped as having moderate cognitive
impairment (i.e., moderate group). Twelve healthy subjects who
had never complained of cognition problems were recruited
(i.e., control group). All of them met the following inclusion
criteria: Aged 50–75 years old, self-reported right handedness,
no family history of dementia, and no history of any psychiatric
or neurological disorders, brain injury, cranial neurosurgery,
alcohol or drug abuse, or any severe chronic systemic illness.
Demographic and clinical data of the patients and controls are
reported in Table 1.
Transcranial Magnetic Stimulation
All patients underwent rTMS treatment. rTMS was delivered
using the MagPro 100 system (MagVenture, Copenhagen,
Denmark) with a figure-8 coil (Coil B658; external wing diameter,
90 mm) placed over F3 (International 10/20 EEG system) to
target the left DLPFC. The resting motor threshold (RMT) was
defined as the minimum stimulus intensity that produces a
motor-evoked potential exceeding 50 µV in a minimum of five
of ten trials in the relaxed right abductor pollicis brevis. All
patients were treated with 1,600 pulses per session at 10 Hz
1https://www.mocatest.org/faq/
(1-s trains, 10-s intertrain interval) with 100% RMT intensity.
The treatment included 20 sessions of rTMS for 2 weeks [two
sessions per day (one in the morning and the other in the
afternoon) with approximately 4–6 h between the two sessions;
sessions were administered for 5 days per week]. The controls did
not receive the RMT examination or any rTMS session.
Behavioral Assessment
For behavioral assessments, patients completed
neuropsychologic tests, including the MoCA and 24 items-
HAMD, on the day before rTMS and on the day after completing
the last rTMS session. The same trained neurologist conducted
behavioral evaluations of each patient to minimize variability
and inter-rater bias.
EEG Recordings and Preprocessing
Resting-state EEGs were recorded on the day before rTMS
and on the day after completing the last rTMS session. An
eyes-closed resting-state EEG was recorded for 8 min by
using a BrainAmp DC amplifier (Brain Products, Munich,
Germany) with a 64-channel EEG system. Participants were
asked to remain still and relaxed during the EEG recording.
The sampling rate was maintained at 5,000 Hz, and electrode
impedances were maintained below 5 k by applying the
conductive gel. FCz was the reference electrode, and AFz
was the ground electrode during the EEG recording. EEG
data were preprocessed offline in MATLAB (R2018a; The
MathWorks Inc., Natick, MA, United States) by using a
custom script based on EEGLAB (Delorme and Makeig,
2004). The EEG preprocessing steps were: (a) removing
typical artifacts by visual inspection; (b) down-sampling to
250 Hz; (c) notch filtering (48–52 Hz) to remove 50 Hz line
noise and its harmonics; (d) bandpass filtering between 1
and 45 Hz using a zero-phase finite impulse response filter;
(e) rejecting bad channels and spherically interpolating
rejected channels; (f) the signals were then segmented
into 2-s; (g) removing remaining artifacts by independent
components analysis, including ocular, heartbeat, and high-
frequency persistent muscle artifacts, and (h) re-referencing to
the common average.
Source-Level PEC Calculation
The estimation of PEC between orthogonalized signals at the
source-level was calculated as described in a previous study
(Zhang et al., 2020). Source localization was performed via
TABLE 1 | Demographic and clinical data.
Control Mild Moderate
N 11 12 11
Age (years) 63.7 ± 2.0 65.8 ± 8.4 70.2 ± 5.8
Sex (male/female) 3/9 5/7 4/7
Education (years) 10 ± 5.7 11.1 ± 5.2 11.7 ± 3.3
RMT (%) / 31.6 ± 9.7 30.4 ± 9
MoCA (baseline) 29.2 ± 1.1 23.2 ± 3.7 13.4 ± 2
HAMD (baseline) 4.6 ± 2.5 9.8 ± 4 9.9 ± 6.1
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custom scripts and the publicly available toolbox Brainstorm
(Tadel et al., 2011). Rotating dipoles at 3003 vertices on the
cortical surface were generated. Pearson’s correlation coefficients
between the log-transformed power envelopes were thereafter
obtained for each pair of vertices. Functional connectivity was
calculated among 31 brain regions in the Montreal Neurological
Institute space, derived from an independent parcellation of
resting-state functional magnetic resonance imaging (fMRI)
connectivity using an independent components analysis of 38
healthy individuals derived in a previous study (Chen et al., 2013).
For each pair of regions, the Fisher-Z transforms of the Pearson’s
correlations of each pair of vertices within each of the regions
were averaged to determine the connectivity of that specific
pair of regions. A total of 465 pairs of PECs (excluding self-
connectivity) was computed for each of the five frequency bands
(delta, 1–4 Hz; theta, 5–7 Hz; alpha, 8–12 Hz; beta, 13–30 Hz; and
gamma, 31–45 Hz).
Statistical Analyses
Statistical analyses were conducted using SPSS version 11.0
(SPSS, Inc., Chicago, IL, United States) and MATLAB (The
MathWorks Inc.). Normality was checked using the Shapiro–
Wilk test. Age, years of education and behavioral measurements
(i.e., MoCA and HAMD) were compared between the two
patient groups and the control group using one-way analysis of
variance. Bonferroni correction was used for post-hoc analysis.
Sexes were compared using the Fisher’s exact test. Duration
of illness and RMT between the two patient groups were
compared using the independent samples t-test. Behavioral
measurements obtained pre- and post-rTMS treatment were
compared using the paired t-test or the Wilcoxon matched-pairs
signed ranks test. Treatment effect sizes were calculated using
Cohen’s d (Behl et al., 2014). Correlation analysis between the
MoCA and HAMD at baseline was conducted using Pearson’s
correlation. Network-based statistics (NBS) were used to evaluate
clinical group differences in the functional connectivity matrices
with revealing a statistically significant network, using the
NBS toolbox (Zalesky et al., 2010). The average connectivity
strength in the significant network was calculated, and its
changes from pre- to post-rTMS was correlated with the
changes of MoCA using Pearson’s correlation. The sum of the
number of NBS survived edges (survived edges means edges
composing the significant network in the comparison between
groups using NBS) for each node was computed. The three-
dimensional brain network differences were visualized using the
BrainNet Viewer toolbox (National Key Laboratory of Cognitive
Neuroscience and Learning, Beijing Normal University, Beijing,
China) (Xia et al., 2013).
RESULTS
Participants
Both patients and controls successfully completed all EEG
examinations and behavioral assessments. All patients tolerated
rTMS well with no reports of adverse effects. No significant
differences were found between the two-group patients and
controls in age (F = 3.25, p = 0.06), years of education (F = 0.15,
p = 0.06), or sex (p = 0.90, Fisher’s exact test). The MoCA scores
ranged from 10–17 for the moderate group and 18–28 for the
mild group. No significant difference was found between the
mild and moderate cognitive impairment groups in terms of the
RMT [t(21) = 0.35, p = 0.72]. There were significant differences
between the patient groups and the control group in HAMD
(F = 5.1, p = 0.01). Post-hoc test showed a higher HAMD score in
the mild and moderate groups than in controls (mild vs. control,
p = 0.03; moderate vs. control, p = 0.03), and no significant
differences between the mild and moderate group (p > 0.99).
No correlation was found between the MoCA and HAMD scores
at baseline in the mild (p = 0.71, r = 0.12) or moderate groups
(p = 0.39, r = 0.26).
Abnormal Functional Connectivity in AD
Pre-rTMS
In general, NBS identified a network of stronger connectivity
in the delta and theta band across the whole brain separately,
and a network of weaker connectivity in the beta band in the
moderate group, compared to the control or mild group at
baseline. In the alpha and gamma band, no significant difference
existed between the moderate group and the other two groups.
No significant difference existed between the mild and control
group at any frequency band. The abnormal networks identified
in AD patients are as follows.
In the delta band, a comparison of PEC between the moderate
group and controls by NBS yielded a network of 31 nodes and 433
edges; the connectivity strength was higher in moderate group
patients (Figures 1A,B, p < 0.05, Bonferroni-corrected). Regions
in the bilateral frontal, parietal, temporal, occipital, insular, and
limbic lobes and nearly all edges between them were involved
in this network. There was no significant difference between the
mild group and the control or moderate group.
In the theta band, a network of 31 nodes and 307 edges with
a higher PEC was identified by NBS in the moderate group,
compared to controls (Figures 2A,B, p < 0.05, Bonferroni-
corrected). Regions across the whole brain were involved in
this network. Regions in right posterior areas, such as the right
sensorimotor cortex, supramarginal gyrus, intraparietal sulcus,
inferior parietal lobule, angular gyrus, and primary visual cortex,
had a relatively lower sum of survived edges. A comparison
between the mild group and the control or moderate group
did not reveal any significant difference (p > 0.05), though an
increase tendency of the connectivity strength than the control
was observed in the mild group.
In the beta band, the comparison between the moderate and
control group yielded a network of 31 nodes and 453 edges with
a significantly lower PEC strength in the moderate group by
NBS (Figures 3A,B, p < 0.05, Bonferroni-corrected). Regions
across the whole brain and nearly all edges between them were
involved in this network. Meanwhile, the comparison between
the moderate and mild groups revealed a network of 31 nodes
and 335 edges with lower connectivity in the moderate group
(Figures 3A,C, p < 0.05, Bonferroni-corrected). Regions in the
bilateral frontal lobes such as the bilateral anterior division of
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FIGURE 1 | Higher connectivity in the delta band in Alzheimer’s disease patients with moderate cognitive impairment before and after repetitive transcranial magnetic
stimulation (rTMS). (A) Power envelope connectivity matrices of the control, mild, and moderate groups pre-rTMS. (B) The network-based statistics results of
moderate group > control group pre-rTMS. (C) Power envelope connectivity matrices of the control, mild, and moderate groups post-rTMS. (D) The network-based
statistics results of moderate group > control group post-rTMS. In (B,D), the connectivity difference matrix (left panel) and its three-dimensional visualization (right
panel) are shown. In the matrix, the red squares indicate the survived edges from the network-based statistics analysis. The size of the node represents its sum of
the survived edges; the larger the node, the greater the sum, and vice versa. The three-dimensional visualization shows the left, up, and right views of the brain. For
all figures (“L” and “R” in front of certain abbreviations (e.g., ORB, AMFG, FEF) means “left” and “right,” respectively): ORB, orbitofrontal cortex; AMFG, anterior
division of middle frontal gyrus; FEF, frontal eye field; SEF, supplementary eye field; PMFG, posterior division of middle frontal gyrus; IFJ, inferior frontal junction; SMC,
somatosensory cortex; SUP, supramarginal gyrus; IPS, intraparietal sulcus; IPL, inferior parietal lobule; ANG, angular gyrus; V1, primary visual cortex; MTG, middle
temporal gyrus; INS, insular cortex; MPFC, medial prefrontal cortex; DACC, dorsal anterior cingulate cortex; PCC, posterior cingulate cortex. F, frontal cortex; P,
parietal cortex; lim, limbic lobe.
Frontiers in Aging Neuroscience | www.frontiersin.org 5 July 2021 | Volume 13 | Article 679585
fnagi-13-679585 July 1, 2021 Time: 16:14 # 6
Guo et al. rTMS Functional Modulation in AD
FIGURE 2 | Higher connectivity in the theta band in Alzheimer’s disease patients with moderate cognitive impairment before and after repetitive transcranial
magnetic stimulation (rTMS). (A) Power envelope connectivity matrices of the control, mild, and moderate groups pre-rTMS. (B) The network-based statistics results
of moderate group > control group pre-rTMS. (C) Power envelope connectivity matrices of the control, mild, and moderate groups post-rTMS. (D) The
network-based statistics results of moderate group > control group post-rTMS. In (B,D), the connectivity difference matrix (left panel) and its three-dimensional
visualization (right panel) are shown. The three-dimensional visualization shows the left, up, and right views of the brain. The meaning of the red squares, size of
node, and all abbreviations are the same as in Figure 1.
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middle frontal gyrus, frontal eye field, supplementary eye field,
posterior division of middle frontal gyrus, and inferior frontal
junction had a lower sum of survived edges. No significant
difference was found in the comparison between the mild
and control groups.
Effects of rTMS on Clinical Performance
General cognitive function improved after rTMS treatment
because the MoCA scores significantly increased after rTMS
treatment in the mild group [pre-rTMS, 23.2 ± 3.7; post-rTMS,
25.5 ± 3.9; t(11) = 3.44; p = 0.01; Cohen’s d = 0.99] and in the
moderate group [pre-rTMS, 13.4 ± 2; post-rTMS, 17.2 ± 3.31;
t(10) = 3.37; p = 0.01; Cohen’s d = 1.01]. Depressive symptoms
were not ameliorated because no statistical differences were
found between the pre- and post-rTMS HAMD scores in the mild
group [pre-rTMS, 9.8 ± 3.9; post-rTMS, 5.9 ± 4.8; t(11) = 2.03;
p = 0.07] or in the moderate group [pre-rTMS, 9.9 ± 6.1; post-
rTMS, 7.5 ± 5.4; t(10) = 1.39; p = 0.20].
Effects of rTMS on Functional
Connectivity
After rTMS treatment, stronger PEC networks in the delta and
theta bands across the whole brain were persistently identified in
the moderate group compared to the control group (p < 0.05,
Bonferroni-corrected). The network in the delta band involved
31 nodes and 379 edges (Figures 1C,D). The network in the
theta band involved 31 nodes and 323 edges (Figures 2C,D). No
significant difference was revealed in the beta band between the
moderate group and the control group after rTMS (Figure 3D).
No significant difference was found between the PEC of the mild
group post-rTMS and the control group.
Importantly, NBS identified one network in the beta band in
the comparison of the PEC between pre- and post-rTMS in the
moderate group (Figure 4, p < 0.05, Bonferroni-corrected). The
network of 31 nodes and 265 edges was yielded with increased
PEC after rTMS treatment, and nodes in the left parietal-occipital
regions such as the left somatosensory cortex, supramarginal
gyrus, intraparietal sulcus, inferior parietal lobule, angular gyrus,
primary visual cortex, and the left middle temporal gyrus had a
relatively higher sum of survived edges. Moreover, the increase of
the connectivity strength in this network was positively correlated
with the increase of MoCA scores after rTMS treatment (r = 0.75,
p = 0.01). No significant difference in PEC was found between
pre- and post-rTMS in the delta (Figures 1A,C, p > 0.05) and
theta (Figures 2A,C, p> 0.05) bands, though a decrease tendency
was observed in the delta band. In the mild group, no significant
difference was found in a comparison of the PEC between the pre-
and post-rTMS PEC in these frequency bands.
DISCUSSION
This study was an investigation of how DLPFC rTMS
exerts its effects of improving cognition by altering
electroencephalographic functional connectivity in AD.
Compared to controls, AD patients with moderate cognitive
impairment had increased connectivity in the delta and theta
bands but decreased connectivity in the beta band. With
rTMS treatment, beta connectivity increased along with an
improvement in cognitive function in patients with moderate
cognitive impairment, whereas there were no significant
alterations of the connectivity in the delta and theta bands.
However, these baseline abnormalities and rTMS modulation
effects were not found in AD patients with mild cognitive
decline.
According to the diagnostic guidelines of the International
Working Group and the US National Institute on Aging
Alzheimer’s Association (NIA-AA), AD status is associated with
β-amyloid (Aβ) pathology, tau pathology, other biomarkers of
neurodegeneration such as fluorodeoxyglucose positron emission
tomography (Dubois et al., 2014; Jack et al., 2018). Although these
methodologies refine the pathophysiology and staging of AD,
their uses are limited in the general clinical practice because of the
invasiveness or cost. In this regard, other non-invasive and cost-
effective modalities associated with disease stage and cognitive
symptoms, such as EEG as well as motor assessment, should be
stated as integral components in the clinical work-up (Voglein
et al., 2019; Babiloni et al., 2020).
In EEG studies, a lower beta coherence in patients with
AD than in controls has been consistently reported (Adler
et al., 2003; Pogarell et al., 2005; Fonseca et al., 2011).
Decreased connectivity in the beta rhythm has been cross-
validated by alternative techniques such as phase lagged index
and synchronization likelihood (Stam et al., 2005; Babiloni
et al., 2020). The present study displayed significantly decreased
beta PEC in patients with moderate cognitive impairment, but
not in patients with mild cognitive impairment, compared to
controls. In contrast to the coherence and phase lagged index,
PEC measures the correlation between slowly fluctuating power
envelope signals, independent of the signal phase (Hipp et al.,
2012). PEC is more reliable than the phase lagged index for
examining AD neurophysiology by EEG (Briels et al., 2020b).
An MEG study, which enrolled AD patients with a Mini-
Mental State Examination score ≥ 19, reported disrupted beta
PEC in AD patients (Koelewijn et al., 2017). These differences
between the MEG and EEG findings might be because of
the different signal-to-noise ratios of these two modalities,
or because patients with different severity levels of cognitive
dysfunction and different measurement methods were used in
different studies. Of importance, the effects of rTMS on the
functional connectivity were limited to the beta band but not
the delta and theta bands in this study, and the more increase
of beta connectivity strength, the more increase of MoCA
scores after rTMS. Similarly in major depressive disorder and
bipolar disorder, rTMS to the left prefrontal cortex at 10 Hz
increased EEG functional connectivity in the beta band (Kito
et al., 2017; Zuchowicz et al., 2018). The functions of beta
oscillation are not well understood at present. Beta activity
has traditionally been associated with sensorimotor processing,
and recent research has suggested its role in various cognitive
functions (Spitzer and Haegens, 2017). During working memory
tasks, the frontal cortex is synchronized with the parietal,
temporal, or occipital cortices via beta oscillations (Salazar et al.,
2012; Mendoza-Halliday et al., 2014). Beta activity may also be
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FIGURE 3 | Weaker connectivity in the beta frequency band in Alzheimer’s disease patients with moderate cognitive impairment before repetitive transcranial
magnetic stimulation (rTMS). (A) Power envelope connectivity matrices of the control, mild, and moderate groups pre-rTMS. (B) The network-based statistics results
of control group > moderate group pre-rTMS. Connectivity difference matrix (left panel) and its three-dimensional visualization (right panel) are shown. (C) The
network-based statistics results of mild group > moderate group pre-rTMS. (D) Power envelope connectivity matrices of the control, mild, and moderate groups
pre-rTMS. In (B,C), the connectivity difference matrix (left panel) and its three-dimensional visualization (right panel) are shown. The three-dimensional visualization
shows the left, up, and right views of the brain. The meaning of the red squares, size of node, and all abbreviations are the same as in Figure 1.
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FIGURE 4 | Repetitive transcranial magnetic stimulation (rTMS) improves power envelope connectivity in the beta band in Alzheimer’s disease patients with
moderate cognitive impairment. The network-based statistics results of post-rTMS > pre-rTMS in moderate group was shown. Connectivity difference matrix (left
panel) and its three-dimensional visualization (right panel) are shown. The three-dimensional visualization shows the left, up, and right views of the brain. The
meaning of the red squares, size of node, and all abbreviations are the same as in Figure 1.
related to maintaining the current cognitive state (Engel and
Fries, 2010). It has been found that the generation of the beta
rhythm is partially linearly dependent on the concentration of
inhibitory γ-aminobutyric acid in the brain (Gaetz et al., 2011).
Increasing evidence has emerged to disclose the dysfunction
of γ-aminobutyric acid-ergic signaling system are implicated
in the pathophysiology of AD (Li et al., 2016). The elevated
prefrontal cortex γ-aminobutyric acid had been implicated
in the mechanism of action of high-frequency rTMS (Dubin
et al., 2016). Thus, high-frequency rTMS may modulate the
beta rhythm by influencing the activity of γ-aminobutyric acid.
Though no significant correlation between the change of beta
connectivity and the alteration of the depressive symptom after
rTMS in major depressive disorder (Kito et al., 2017), here
we also found that the increase of the beta connectivity was
positively correlated with the improvement of general cognitive
function with rTMS treatment. Perhaps the concentration of
γ-aminobutyric acid which contributed to the generation of beta
rhythm and the cognitive function was improved by rTMS.
Though further research is required, these findings indicate the
role of beta connectivity in cognitive impairment and may be a
mechanism underpinning physiological changes to the human
cortex after rTMS.
Delta and theta oscillations have been proved to be involved
in multiple cognitive processes (Harmony, 2013; Solomon et al.,
2017). However, variable results of altered connectivity in the
delta and theta bands have been reported in AD, with findings of
the connectivity being globally or locally increased or decreased
(Babiloni et al., 2016; Gouw et al., 2017). The current EEG
study showed that AD patients with mild cognitive impairment
had no significant alteration in delta and theta PEC, while
patients with moderate cognitive impairment had higher delta
and theta PEC than controls. The MEG study mentioned above
also reported no significant abnormalities in the delta and theta
PEC in patients with a Mini-Mental State Examination score ≥ 19
(Koelewijn et al., 2017). The effects of rTMS on the delta and
theta bands are also inconclusive with lack of enough evidence.
As the two above mentioned studies, although both observed
increase of beta connectivity after 20 sessions 10 Hz rTMS, one
reported no significant changes of lagged phase synchronization
in delta and theta bands in treatment-resistant depression (Kito
et al., 2017), the other found the different change tendency
of phase locking value in rTMS responder or non-responders
(Zuchowicz et al., 2018). The different functional connectivity
measures and frequency band can influence the EEG studied
outcome. It was demonstrated that the reproducible effects of
orthogonalized amplitude envelope correlation were found in the
alpha and beta bands, while phase-based measures in the theta
band (Briels et al., 2020a). The effects of 10 Hz rTMS on the
slow-wave connectivity deserve further studies.
The DLPFC is one of the most popular targets in cognition
rTMS studies. It lies primarily in Brodmann areas 46, 9, and
9/46 and is involved in various cognitive functions such as
memory, attention, and execution (Carlen, 2017). Anatomical
evidence derived from non-human primate studies using direct
anterograde and retrograde tracing has defined local projections
within the prefrontal cortex in conjunction with long connection
pathways between the prefrontal cortex and the parietal,
occipital, temporal, insular, and limbic lobe (Yeterian et al.,
2012). Neuroimaging studies using fMRI and diffusion tensor
imaging have shown equivalent connectivity patterns in the
human and non-human primate brain (Thiebaut de Schotten
et al., 2012), which shows that use of non-human primate
data to understand human brain connectivity is reasonable. In
fMRI studies (Beynel et al., 2020), rTMS-induced functional
connectivity changes occurred within the stimulated site locally
and across the whole-brain network. The current EEG study
indicated that rTMS over the left DLPFC significantly improved
beta connectivity at a whole-brain level, especially in the left
parietal-occipital regions. Based on the anatomical basis of
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brain connectivity and the rTMS feature of influencing areas
distant from the stimulation site, the significant changes in
the left parietal-occipital cortex connectivity after left DLPFC
rTMS are understandable. Moreover, the lateral parietal cortex
has projections to the hippocampus and an important role in
memory (Wagner et al., 2005). High-frequency rTMS over the
left parietal cortex improved associative memory performance
and concomitantly increased functional connectivity between the
hippocampus and the left lateral parietal cortex, as well as the
hippocampal intrinsic connectivity networks (Wang et al., 2014).
Whether targeting the left parietal cortex would be alternative or
complementary to the left DLPFC rTMS for improving cognitive
functions deserves thorough investigation.
In addition, the DLPFC is a prominent region where
cognition and emotion interact (Ray and Zald, 2012). The
stimulation protocol of 10-Hz rTMS over the left DLPFC is
primally a strategy for treating depression. Whether the effects
of rTMS on cognitive function in this study were just an
appendage of improved depressive symptoms should not be
ignored. However, our results showed no significant remission
of depressive emotion in this cohort of patients with AD who
presented with some depressive symptoms in the mild and
the moderate group. A previous study (Ahmed et al., 2012)
reported that 20-Hz rTMS over the bilateral DLPFC, one session
per day for 5 consecutive days, improved both Mini Mental
State Examination and the Geriatric Depression Scale scores in
AD. This finding may differ from that of this study because
of the variation in the stimulation protocol or the distinct
measurements used.
rTMS effects may rely on the brain status, which may differ
from the intrinsic ability to compensate or restore impaired
neuronal function. Previous investigators have reported that
rTMS improves action, but not object naming accuracy, in
mild AD, and that it improves both features in moderate/severe
AD (Cotelli et al., 2008). This finding suggests that rTMS has
distinct effects for different states of cognitive impairment. In this
study, although general cognition was enhanced in the mild and
moderate groups after rTMS, functional connectivity was only
altered in the moderate group. The unchanged connection in the
mild group may derive from its relative normality at baseline.
Of course, more sensitive EEG biomarkers for distinguishing
between AD patients with mild cognitive impairment and healthy
controls should be defined and used in future studies. The
correlation between the severity of cognitive impairment and
PEC should be examined using a larger dataset. In addition,
we noticed that, because the MoCA tests were performed in
the same manner before and after rTMS treatment in this
study, some patients may have learned or practiced tasks to
perform better over time, as previously reported (Rutherford
et al., 2015). This factor may be more likely and may more
easily occur among patients with mild cognitive decline. If the
cognitive improvement resulted from practice rather than from
an rTMS effect, then more objective and sensitive tools such
as EEG features should potentially be used complementarily
for assessing rTMS efficacy, as in AD clinical trials of drugs
(Rodriguez et al., 2002; Adler et al., 2004; Scheltens et al.,
2018).
Some limitations existed in this study. The lack of a sham
stimulation group prevented us from determining whether
some treatment effects were placebo-related. However,
evidence from previous studies supports the treatment
efficacy of rTMS for cognitive enhancement in people
with AD (Chou et al., 2020). In addition, the purpose of
this study was to gain insight into the role of functional
connectivity as a mechanism facilitating improvements in
cognitive function with rTMS. A further limitation is that the
diagnostic criteria for probable AD were primarily based on
clinical manifestations and not on biological markers of the
cerebrospinal fluid because of the lack of patient agreement
and unavailability of positron emission tomography at our
hospital. The use of same version of MoCA for pre- and
post-rTMS with interval of 2 weeks was another limitation. In
addition, we used 31 brain regions derived from independent
component analysis parcellation of fMRI connectivity which
might introduce an overlapping effect on the EEG signal.
Moreover, the sample size was small, and patients aged 50–
75 years were included, covering the early onset and the
late-onset AD which might involve different mechanisms.
Pathological markers for AD diagnosis, comprehensive
neurological measurements and larger sample sizes separating
early-onset and the late-onset AD should be considered in
future research.
CONCLUSION
We found that AD patients with moderate cognitive impairment
had increased delta and theta connectivity and decreased beta
connectivity, compared to healthy controls. rTMS treatment
led to a significant clinical improvement in cognitive function
and increased functional connectivity in the beta band. The
present results indicated the network level effect of the
rTMS in improving cognitive function in AD and inform
future efforts to optimize rTMS treatment protocols, based on
electroencephalographic functional connectivity. Furthermore,
beyond the cognitive enhancements found in this study, we
propose future research should consider motor symptoms
which are influenced by cognition and could be improved by
neuromodulation techniques in AD.
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